Physician profile
Jamie Gray
NPI 1396995320
$1,280.97
in general payments reported to CMS, 2019-2025
23 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $812 · 2022: $99.00 · 2024: $99.19 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $113.00 | 2021 | |
| Antares Pharma, INC. | $109.42 | 2021-2025 | Xyosted |
| Bioxcel Therapeutics, INC. | $99.19 | 2024 | Igalmi |
| Dendreon Pharmaceuticals LLC | $89.57 | 2021-2025 | Provenge |
| Pfizer INC. | $87.30 | 2021-2022 | |
| Clarus Therapeutics INC. | $85.45 | 2021 | |
| Myovant Sciences INC. | $76.86 | 2021-2022 | |
| Janssen Biotech, INC. | $61.58 | 2021-2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $54.18 | 2021 | |
| Sumitomo Pharma America, INC. | $50.30 | 2025 | Gemtesa |
| Endo Pharmaceuticals INC. | $48.06 | 2021 | |
| Mission Pharmacal Company | $47.55 | 2021-2022 | |
| Teleflex LLC | $45.72 | 2021-2025 | Urolift |
| Medtronic, INC. | $40.81 | 2021 | |
| Abbvie INC. | $40.49 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $40.23 | 2021-2025 | Axonics |
| Blue Earth Diagnostics | $38.54 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $32.35 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.34 | 2025 | |
| Dentsply Ih Ab | $25.77 | 2021 | |
| Urovant Sciences INC | $25.62 | 2021-2022 | |
| Acerus Pharmaceuticals Corporation | $24.53 | 2021 | |
| Avation Medical, INC. | $14.11 | 2025 | Vivally System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.